Moody’s places ProMedica bond rating on review for downgrade

Due to $2.3 billion in outstanding debt, Moody’s Investors Service has put ProMedica Health System’s bond rating on review for downgrade.

Advertisement

“The rating action reflects a material cash flow loss and decline in liquidity through the second quarter of fiscal 2022, both greater than expected,” Moody’s Aug. 22 report said in evaluating the Toledo, Ohio-based health system. “The review will focus on the system’s remediation strategies under the guidance of a turnaround consultant, potential sources of liquidity, and the implications of the severe operating stress on both collateral requirements and covenant compliance.”

The rating action also said its main methodology was based on a study conducted by Moody’s on nonprofit healthcare systems in 2018. 

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.